CD20-specific redirected T cells and their use in cellular immunotherapy of CD20+ malignancies
A Standard patent application filed on 20 October 1999 credited to Raubitschek, Andrew ; Wu, Anna M. ; Jensen, Michael C.

Details

Application number :

24724  

Application type :

Standard  

Application status :

LAPSED  

Under opposition :

No  

Proceeding type :

 

Invention title :

CD20-specific redirected T cells and their use in cellular immunotherapy of CD20+ malignancies  

Inventor :

Raubitschek, Andrew ; Wu, Anna M. ; Jensen, Michael C.  

Agent name :

 

Address for service :

 

Filing date :

20 October 1999  

Associated companies :

 

Applicant name :

City of Hope  

Applicant address :

 

Old name :

 

Original Source :

Go